Various biomarkers linked to the anti-PD-1 response have been explored in HNSCC9, including the Combined Positive Score (CPS) of PD-L1 staining10,11, measuring the proportion of PD-L1-positive cells in a tumor. This evidence concerns the gene CD274 and neoplasm.